Clinical Trial Update: Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies [Phase 3]

View source ↗

Summary

This document reports pharmacoeconomic analyses for Nabi-4514 and Nabi-4515 in Phase 3 smoking cessation trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nabi-4514
• Nabi-4515

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED